The forecast for cardiovascular system medicine sales in the UK from 2024 to 2028 shows a slight decline. Starting at $28.27 in 2024, sales decrease consistently to $28.04 by 2028. This consistent downward trend represents a compound annual growth rate (CAGR) of around -0.2% from 2024 to 2028. Compared to 2023, when sales stood at $28.35, the market is showing a minor contraction.

Future trends to watch for include:

Innovation in drug development, particularly the introduction of novel therapies.
Regulatory changes impacting pricing and access to cardiovascular medicines.
Potential shifts in demographic health trends that could influence demand for services and medications.